1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6337B539221F741C300258A7500445BBF
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-strategic-operations-competitive-intelligence-models-reporting-performance-structure-trends?opendocument
18
19opendocument
2044.210.149.205
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Competitive and Business Intelligence » Structure and Alignment

Strategic Operations in Competitive Intelligence: Models, Reporting, Performance, and Structure Trends

ID: 5782


Features:

6 Info Graphics

13 Data Graphics

140+ Metrics

9 Narratives


Pages/Slides: 25


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Strategic Operations in Competitive Intelligence: Models, Reporting, Performance, and Structure Trends”

STUDY OVERVIEW

In the ever-evolving biopharma landscape, it is imperative to have an acute understanding of the transformative trends shaping Competitive Intelligence (CI). Navigating this complex landscape demands locked-in CI, strategically aligned and armed with cutting-edge capabilities.

This Best Practices, LLC study extensively probes the biopharma Competitive Intelligence landscape, uncovering pivotal shifts and priorities that define the future of Competitive Intelligence. It delivers benchmarks around the structures, reporting mechanisms, performance metrics, budget, and the utilization of Centers of Excellence.

KEY TOPICS

  • Competitive Intelligence Leadership
  • Reporting Levels
  • Competitive Intelligence Group Composition
  • Operating Models
  • CI Budget Coordination
  • Centers of Excellence

KEY METRICS

  • Shift in CI operating model from 2001 to 2023 – A longitudinal view
  • What is the full job title of the person directly managing the CI group or function?
  • What is the job level of the person to whom the leader (direct manager) of the CI function directly reports?
  • What is the functional area of the person to whom the leader (direct manager) of the CI function directly reports, both in large and small organizations?
  • How is the CI team composed at large and small companies?
  • What is the current operating model for Competitive Intelligence functions in large and small organizations?
  • What operating model is planned for use by the CI function within the next 24 months?
  • Where does the budget reside for CI activities in large and small companies?
  • Where does the Center of Excellence sit within the organization?

SAMPLE KEY FINDINGS

  • Shifting Competitive Intelligence Models: Decentralization on the Rise - The need for handling vast data sets with limited budgets is pushing most CI setups towards decentralization, especially in large organizations. Smaller to mid-sized pharmaceutical companies, however, still find centralized structures more effective.

METHODOLOGY

Best Practices, LLC engaged Competitive Intelligence leaders from 22 Life Science companies in this study to uncover insights and lessons learned regarding their evolving CI operations.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Manufacturing; Biotech; Consumer Products; Medical Device; Biopharmaceutical; Chemical; Clinical Research; Laboratories


Companies Profiled:
Abbott; AbbVie; Bayer; BioMarin; Biotest AG; Cerevel Therapeutics; Clovis Oncology; CSL Behring; Daiichi Sankyo; Genentech; Ipsen; Kala Pharmaceuticals; Inc.; Novartis; Novo Nordisk; Paratek Pharmaceuticals; Pfizer; Regeneron; SCIEX; Sanofi; Servier; Takeda Pharmaceuticals; Vincerx Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.